Lannett Company, based in Philadelphia, PA, has been a trusted provider of high-quality and affordable generic pharmaceutical products for over 75 years. With a patient-centric approach, they manufacture over 100 unique pharmaceutical product families for various therapeutic areas, prioritizing the highest quality standards. Their culture combines a legacy of quality with a drive for innovation, making them a sought-after employer for individuals passionate about making medicines that save and enhance lives.
Recently, Lannett achieved a significant milestone with the FDA's first-cycle approval of their Abbreviated New Drug Application for Mycophenolate Mofetil for Oral Suspension, a new dosage form for the company. This accomplishment highlights the quality of their filing and the expertise of their product development team. As one of the few competitors in the market, Lannett continues to demonstrate their commitment to providing patients, partners, and the healthcare industry with reliable and effective pharmaceutical solutions.
Generated from the website